Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side
Orbis
640 participants
Aug 25, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses. The main questions it aims to answer are: 1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments? 2. What is the cost-effectiveness, measured as total intervention cost per additional patient complying with the suggested exam?
Eligibility
Inclusion Criteria5
- Diagnosed with DM within the last 6 months
- Over 30 years of age
- Currently treated at the Dinajpur Diabetes Hospital
- Possess a mobile phone to receive voice messages
- Willingness to participate in the study, and ability to give informed consent
Exclusion Criteria2
- Other significant causes of vision loss
- Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participant will receive a message underscoring risk of vision loss from poorly controlled DM, and how this risk can be largely eliminated with excellent compliance with mediations and clinical visits.
Participants will receive a free pair of reading glass at their first appointment
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06968611